Richard Law
Stock Analyst at Goldman Sachs
(0)
# 4408
Out of 5,358 analysts
63
Total ratings
42.86%
Success rate
-10.01%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
OLMA Olema Pharmaceutical... | Maintains: Buy | 20 18 | 4.45 | 304.49% | 5 | May 14, 2025 | |
RCKT Rocket Pharmaceutica... | Maintains: Neutral | 15 13 | 3.06 | 324.84% | 3 | May 9, 2025 | |
CLDX Celldex Therapeutics | Maintains: Neutral | 36 31 | 21.37 | 45.06% | 3 | May 9, 2025 | |
VRDN Viridian Therapeutic... | Maintains: Buy | 31 27 | 14.7 | 83.67% | 3 | May 7, 2025 | |
MLTX MoonLake | Maintains: Buy | 82 73 | 46.78 | 56.05% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 28 24 | 16.1 | 49.07% | 6 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 11 | 5.02 | 119.12% | 4 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 31 | 6.19 | 400.81% | 2 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 46 47 | 18.55 | 153.37% | 3 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 62 63 | 41.92 | 50.29% | 6 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 36 37 | 47.64 | -22.33% | 8 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 76 | 8.06 | 842.93% | 6 | Jun 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 36 | n/a | n/a | 4 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 15 14 | 1.92 | 629.17% | 3 | May 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Outperform | 61 | 7.53 | 710.09% | 4 | May 8, 2023 |